Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation
F. Baruffaldi, M. D. Raleigh, S. J. King, M. J. Roslawski, Angela K Birnbaum, C. Hassler, F. I. Carroll, S. P. Runyon, S. Winston, P. R. Pentel, Marco Pravetoni
Dive into the research topics of 'Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation'. Together they form a unique fingerprint.